Contact this trialFirst, we need to learn more about you.
Digital Medicine
ABILIFY MYCITE for Schizophrenia
Recruiting5 awardsPhase 4
Durham, North Carolina
This study is evaluating whether a digital medicine system (DMS) is more effective than treatment as usual (TAU) for adult patients with schizophrenia, bipolar I disorder, and major depression.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.